A blog about chemistry, drug development, science, and technology
C&EN had a nice article on the year in review for the pharmaceutical industry. I’m just now getting caught up on some reading and wanted to let readers know of this, although most may have already read it.
Chemical & Engineering News: Cover Story - Pharma Challenged
One of the facts that stuck out to me was that the US represents 45% of worldwide shares. There is the chart showing other countries. It isn’t stated but I’m assuming this is only for brand name pharmaceuticals and doesn’t include generics.
This is why everyone concentrates their efforts on approval in the US and why many times companies are willing to accept less than acceptable pricing in other countries and hope to make up the difference in the US.
Here is the same sort of chart for generics from The World Generics Market (pdf). Again the US dominates the market although it is considerably smaller than the one above in terms on revenue.
Technorati Tags: generics, pharma stats, pharma worldwide markets, pharmaceutical companies
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.035 seconds